Antithrombotics in vascular disease and renal dysfunction

Journal of the American College of Cardiology

This analysis evaluated whether the benefits of rivaroxaban 2.5 mg bd plus aspirin, comparedwith aspirin alone, are maintained in vascular patients who also have renal dysfunction.

Fracassi F, Crea F, et al.

Volume 73, Issue 18, May 2019

This study examined the prevalence,morphological features, and significance ofhealed plaques at the culprit site in patients withacute coronary syndromes usingoptical coherence tomography.

Cardiogenic shock classification to predict mortality

This study examined the ability of the Society forCardiovascular Angiography and Intervention cardiogenic shockclassification scheme to predict mortality in unselected cardiac intensive care unit patients.

Long-term efficacy and safety of evolocumab

This analysis of the OSLER-1 studyis the longest follow-upof a proproteinconvertase subtilisin/kexintype 9 (PCSK9) inhibitor to date.